Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Pharmacodynamic Models: Linear Concentration–Effect Model01:15

Pharmacodynamic Models: Linear Concentration–Effect Model

The linear concentration–effect model, underpinned by the principle that pharmacological effect (E) is directly proportional to plasma drug concentration (C), emerges as a pivotal simplification of the Emax model for conditions where C is significantly less than EC50. This model portrays a linear trajectory of the concentration–effect relationship when drug levels are markedly below the EC50 threshold.Despite its inherent assumption of continuous effect augmentation with increasing drug...
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The crucible of resilience: hormesis as the unifying principle of evolution, genetics, and epigenetics.

Archives of toxicology·2026
Same author

Hormesis in biomedical and toxicological models: A generalizable phenomenon induced by per- and polyfluoroalkyl agents.

Chemico-biological interactions·2026
Same author

Canine environmental health: An EPA blind spot? Canine physiology, environmental exposure, and the regulatory gap in U.S. policy.

Regulatory toxicology and pharmacology : RTP·2026
Same author

Hormetic effects of per- and polyfluoroalkyl substances on ecologically relevant animal models: Generality, quantitative features, and risk assessment implications.

Environmental pollution (Barking, Essex : 1987)·2026
Same author

How the US NAS BEAR I Genetics Panel scientific misconduct could have been avoided, but was not.

Journal of occupational and environmental hygiene·2026
Same author

BEAR I Genetics Panel: An unexpected and troubling historical twist: The untold story of Hermann Muller's significant scientific confusion.

Journal of occupational and environmental hygiene·2026

Related Experiment Video

Updated: Jun 8, 2026

A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans
09:01

A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans

Published on: March 14, 2019

Predicting low dose effects for chemicals in high through-put studies.

Edward J Stanek1, Edward J Calabrese

  • 1Division of Biostatistics and Epidemiology, University of Massachusetts.

Dose-Response : a Publication of International Hormesis Society
|September 30, 2010
PubMed
Summary

This study introduces a novel estimation approach for high-throughput screening (HTS) data. It accurately assesses chemical responses at low doses, revealing insights often missed by traditional statistical methods.

More Related Videos

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

Related Experiment Videos

Last Updated: Jun 8, 2026

A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans
09:01

A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans

Published on: March 14, 2019

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

Area of Science:

  • Toxicology and Pharmacology
  • Computational Biology
  • Biostatistics

Background:

  • High-throughput screening (HTS) commonly employs 96-well plates to test multiple chemicals across various doses.
  • Dose-response studies in HTS often aim to determine the LC50 (lethal concentration 50%) but may include doses below a benchmark dose with no apparent adverse effects.
  • Traditional statistical methods may overlook subtle low-dose responses in complex HTS datasets.

Purpose of the Study:

  • To develop and validate an estimation approach for interpreting low-dose chemical responses from HTS data.
  • To provide a method for obtaining interpretable results regarding chemical effects in the low-dose region.
  • To enhance the understanding of chemical toxicity at environmentally relevant low concentrations.

Main Methods:

  • Utilized data from a high-throughput study involving 2189 chemicals tested on yeast.
  • Employed best linear unbiased predictors (BLUPs) within a mixed-effects model for accurate response estimation.
  • Summarized results using plots comparing expected responses (assuming no low-dose effect) with confidence intervals for low-dose responses.

Main Results:

  • The estimation approach yielded clearly interpretable results for chemical responses in the low-dose region.
  • Accurate estimates of chemical response were obtained for the studied chemicals.
  • Plots effectively summarized low-dose responses, highlighting deviations from expected no-effect levels.

Conclusions:

  • The proposed estimation approach provides valuable insights into low-dose chemical effects that are often missed by standard statistical analyses.
  • This method enhances the interpretation of HTS data, particularly for understanding subtle toxicological profiles.
  • The findings support the use of advanced statistical modeling for a more comprehensive analysis of high-throughput toxicological studies.